ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CLVS Clovis Oncology Inc

0.0812
0.00 (0.00%)
After Hours
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Clovis Oncology Inc NASDAQ:CLVS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0812 0.0792 0.0811 0 01:00:00

SHAREHOLDER ALERT: Khang & Khang LLP Announces an Ongoing Investigation of Claims against Clovis Oncology, Inc. & Advises Inv...

30/11/2015 1:28am

Business Wire


Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Clovis Oncology Charts.

Khang & Khang LLP announces that it is investigating claims of potential misrepresentations by Clovis Oncology, Inc. (“Clovis” or the “Company”) (NASDAQ: CLVS). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.

If you purchased shares of Clovis during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by email at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The investigation concerns whether the Company violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. Specifically, the investigation will focus on the Company’s November 16, 2015, announcement that potential approval of its lung cancer treatment rociletinib will likely be delayed.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by email at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

KHANG & KHANG LLPJoon M. Khang, Esq.Telephone: 949-419-3834Facsimile: 949-225-4474joon@khanglaw.com

1 Year Clovis Oncology Chart

1 Year Clovis Oncology Chart

1 Month Clovis Oncology Chart

1 Month Clovis Oncology Chart

Your Recent History

Delayed Upgrade Clock